Role of oral tranexamic acid to decrease blood loss during myoma excision surgery
Phase 3
- Conditions
- Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
- Registration Number
- CTRI/2023/04/052073
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA physical status 1 and 2, undergoing laparoscopic myomectomy surgeries
Exclusion Criteria
Patients with medical history of (thromboembolic disease, ischemic heart disease, malignancy, hematuria, liver or kidney disease, or subarachnoid hemorrhage), parturients, nursing mothers, hormonal contraception, on drugs affecting coagulation(factor IX complex concentrates, Anti-inhibitor coagulant concentrates and trans-retinoic acid) and hypersensitivity to tranexamic Acid
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method